Feb 21, 2005

Biotech buying

According to the FT($$),
Novartis will launch an agreed tender offer for the balance of Eon Labs shares at $31 a share, a 25 per cent premium over the pre-takeover speculation price of $24.75 a share.
I mentioned Eon Labs (ELAB) last week for its technical breakout.

No comments:

Post a Comment